207
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Novel lipid–polymer hybrid nanoparticles incorporated in thermosensitive in situ gel for intranasal delivery of terbutaline sulphate

, , &
Pages 577-594 | Received 10 Feb 2020, Accepted 17 Sep 2020, Published online: 02 Oct 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shourya Tripathi, Ujala Gupta, Rewati Raman Ujjwal & Awesh K. Yadav. (2021) Nano-lipidic formulation and therapeutic strategies for Alzheimer’s disease via intranasal route. Journal of Microencapsulation 38:7-8, pages 572-593.
Read now

Articles from other publishers (10)

Israa Habeeb Naser, Muhaned Zaid, Eyhab Ali, Hayder Imad Jabar, Anfal Nabeel Mustafa, Mahmood Hasen Shuhata Alubiady, Montather F. Ramadan, Khursheed Muzammil, Reem Mohsin Khalaf, Sarah Salah Jalal, Ahmed Hussien Alawadi & Ali Alsalamy. (2023) Unveiling innovative therapeutic strategies and future trajectories on stimuli-responsive drug delivery systems for targeted treatment of breast carcinoma. Naunyn-Schmiedeberg's Archives of Pharmacology 397:6, pages 3747-3770.
Crossref
Basma Ibrahiem, Rehab Shamma, Abeer Salama & Hanan Refai. (2023) Magnetic targeting of lornoxicam/SPION bilosomes loaded in a thermosensitive in situ hydrogel system for the management of osteoarthritis: Optimization, in vitro, ex vivo, and in vivo studies in rat model via modulation of RANKL/OPG. Drug Delivery and Translational Research.
Crossref
Enas Elmowafy & Mahmoud E. Soliman. (2023) Polysaccharide-based platforms for nasal delivery: design, features, and perspectives. Journal of Pharmaceutical Investigation 53:5, pages 571-599.
Crossref
Elena O. Bakhrushina, Elizaveta V. Novozhilova, Marina M. Shumkova, Victor S. Pyzhov, Maria S. Nikonenko, Alexander I. Bardakov, Natalia B. Demina, Ivan I. KrasnyukJr.Jr. & Ivan I. Krasnyuk. (2023) New Biopharmaceutical Characteristics of In Situ Systems Based on Poloxamer 407. Gels 9:7, pages 508.
Crossref
Andrea Vaquero-Rodríguez, Jone Razquin, Maider Zubelzu, Raphaelle Bidgood, Harkaitz Bengoetxea, Cristina Miguelez, Teresa Morera-Herreras, Jose Angel Ruiz-Ortega, José Vicente Lafuente & Naiara Ortuzar. 2023. Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-Morbidity Factors Part B. Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-Morbidity Factors Part B 103 143 .
Muhammad Sarfraz, Sara Mousa, Ranim Al Saoud & Raimar Löbenberg. 2023. Nasal Drug Delivery. Nasal Drug Delivery 339 360 .
Chunhui Huang, Canjian Wang, Wenliu Zhang, Tao Yang, Mingyan Xia, Xiaomeng Lei, Ying Peng, Yuhuan Wu, Jianfang Feng, Dongxun Li & Guosong Zhang. (2022) Preparation, In Vitro and In Vivo Evaluation of Nanoemulsion In Situ Gel for Transnasal Delivery of Traditional Chinese Medicine Volatile Oil from Ligusticum sinense Oliv.cv. Chaxiong. Molecules 27:21, pages 7644.
Crossref
Junhu Tai, Munsoo Han, Dabin Lee, Il-Ho Park, Sang Hag Lee & Tae Hoon Kim. (2022) Different Methods and Formulations of Drugs and Vaccines for Nasal Administration. Pharmaceutics 14:5, pages 1073.
Crossref
Bryan J. Mathis, Misa Kusumoto, Alexander Zaboronok & Yuji Hiramatsu. (2021) Packaging and Delivery of Asthma Therapeutics. Pharmaceutics 14:1, pages 92.
Crossref
E. O. Bakhrushina, N. B. Demina, M. M. Shumkova, P. S. Rodyuk, D. S. Shulikina & I. I. Krasnyuk. (2021) <i>In situ</i> Intranasal Delivery Systems: Application Prospects and Main Pharmaceutical Aspects of Development (Review). Drug development & registration 10:4, pages 54-63.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.